On screening 192 men and women aged 35-64 were identified as having two or more of the following risk factors: blood pressure > 140/90 mm Hg, plasma cholesterol concentration > 6-3 mmol/l (243 6 mg/100 ml), and current smoking habit ) 10 cigarettes a day. They were randomly allocated to a group for modification of behaviour or to serve as controls. Both groups were given health education leaflets containing advice to stop smoking, to reduce animal fats in the diet, and on the importance of reducing blood pressure. In addition, the treatment group had group sessions of one hour a week for eight weeks in which they were taught breathing exercises, relaxation, and meditation and about managing stress. It had previously been found that after eight weeks and eight months there was a significantly greater reduction in both systolic and diastolic blood pressures in the group taught to relax compared with the control group. After four years of follow up these differences in blood pressure were maintained. Plasma cholesterol concentration and the number of cigarettes smoked were lower in the treatment group at eight weeks and eight months but not
Introduction
The search for a non-pharmacological method of lowering blood pressure has led to an evaluation of behavioural techniques. Various modes of relaxation can significantly reduce blood pressure1 '5 and, possibly, other cardiac risk factors. 16 18 Many of these studies, however, included only highly motivated volunteers already receiving antihypertensive treatment, for whom follow up was short (at most 15 months) and treatment was given on a one to one basis, which is not suitable for general application.
We conducted a randomised controlled trial in subjects found at screening to have mild untreated hypertension or other cardiac risk factors. We showed that after eight weeks of training subjects taught relaxation had significantly lower blood pressures than controls, and these findings were still in evidence six months later.'9 After four years of follow up we now report changes in blood pressure, plasma cholesterol concentration, and smoking and morbidity from cardiovascular disease.
Subjects and methods
A group of 1268 men and women employed by one industry and aged 35-64 were invited for screening; 1132 attended. Blood pressure was measured by a trained nurse with a random zero sphygmomanometer after the subjects had been sitting quietly for five minutes. Diastolic blood pressure was measured at phase V (disappearance of Korotkoff sound). We recalled subjects with two or more of the following risk factors: an average of two measurements of blood pressure of 140/90 mm Hg and not taking antihypertensive drugs; non-fasting plasma cholesterol concentration of >6 3 mmol/l (244 mg/100 ml);
and a current cigarette consumption of > 10 cigarettes a day. Of the 312 subjects invited for re-examination, 289 attended. Each subject completed three self administered 24 hour dietary recall diaries. At this stage 59 subjects were excluded because they no longer had two or more risk factors as defined. Of the 230 subjects who qualified for the study, 204 agreed to participate. The subjects were then randomly allocated to a treatment or a control group. 
Results
Of the 107 subjects allocated to the group taught to relax, 99 completed the eight week programme, while ofthe 97 allocated to the control group, 93 completed the programme. The characteristics of the 12 people who dropped out of the study soon after randomisation were similar to those of the 192 subjects who completed the eight week follow up examination. Table I shows that the treatment and control groups were comparable at entry. Systolic blood pressure and current smoking habit were slightly higher in the treatment group; serum cholesterol concentrations were slightly higher in the control group.
Further analysis was restricted to those who were available at the four year follow up. Of the 99 subjects in the group taught to relax, eight were lost to follow up and two had died; 89 filled in the questionnaire, of whom 86 were examined (91 accounted for). Of the 93 subjects in the control group, nine were lost to follow up and two had died; 82 filled in the questionnaire, of whom 75 were examined (84 accounted for). Table II shows that at eight weeks, eight months, and four years there were significantly greater falls in both systolic and diastolic blood pressures in those taught relaxation than in the controls. This was true for men and women analysed separately. tValues missing in one subject at eight weeks and three subjects at eight months and four years, respectively. IValues missing in two, six, and four subjects at eight weeks, eight months, and four years, respectively. §Values missing in one, two, and three subjects at eight weeks, eight months, and four years, respectively.
lValues missing in two, five, and three subjects at eight weeks, eight months, and four years, respectively.
Conversion: SI te traditional units-Cholesterol: 1 mmol/l 38-6 mg/100 ml.
Both groups were given health education literature on stopping smoking, reducing dietary cholesterol and animal fats, and high blood pressure and its treatment. The treatment group also had group sessions of one hour a week for eight weeks to learn breathing exercises, deep muscle relaxation, and meditation as well as a stress management programme described previously.19 They were asked to practise relaxation and meditation for 15-20 minutes twice daily and to try to relax during everyday activities, such as while waiting at red traffic lights, before picking up a telephone, and every time they looked at their wrist watches. The subjects were lent a tape recording on relaxation to use at home. Assessments were made at eight weeks, eight months, and four years of smoking (by questionnaire); blood pressure, plasma cholesChanges in blood pressure were also analysed separately for those with initially high pressures ( 140/90 mm Hg) and those with initially normal pressures (< 140/90 mm Hg) (figure). The number of subjects in each group was small, but the group taught to relax showed a consistent advantage over the control group in both subgroups based on initial blood pressure.
Plasma cholesterol concentration was reduced in both groups at eight weeks and eight months (table II) . The mean fall in the group taught to relax was not significantly different from that in the control group. In those with an initial plasma cholesterol concentration of -6 3 mmol/1 (244 mg/100 ml), however, the fall was significantly greater in the group taught to relax than in the controls at eight weeks (fall of 0-89 mmol/l (34 4 mg/100 ml) v 0-53 mmol/l (20 5 mg/100 ml)).
The groups were comparable at entry to the study with respect to total energy and amount of different fats consumed. There were small changes in both the groups which were slightly greater in the control group at eight weeks, giving a ratio of polyunsaturated to saturated fat of 0 3 in the controls compared with 0-2 in the group taught to relax. Alcohol consumption was similar in both groups as was body weight, which did not change significantly. Thus the greater reductions in serum cholesterol concentration and blood pressure in the treatment group compared with the controls are unlikely to have been due to changes in diet or body weight. At the four year follow up only 14 of 81 subjects in the group taught to relax said that they were regularly practising relaxation, and of these only three had practised at least once a day in the previous week. An additional 27 had practised relaxation in the last six months.
However, 51 (630%) said that they sometimes and 16 (20",,) that they often integrated relaxation into their everyday life, and 73 (9000) said that they often or sometimes told themselves to calm down under pressure. Thus most subjects were not spending the recommended 15-20 minutes daily relaxing and meditating, but many had changed their style of coping and were either cognitively or physically relaxing in their everyday life.
Those who had relaxed regularly showed greater reduction in mean systolic and diastolic blood pressures (10 9 and 7 0 mm Hg, respectively) than those who did not (6 3 and 1 7 mm Hg, respectively). Similarly, those who regularly integrated relaxation into their everyday life and those who told themselves to calm down under pressure (cognitive reappraisal) showed greater reduction in blood pressure compared with those who had not changed their behavioural or cognitive styles of coping.
Morbidity during the four years was assessed by a questionnaire and electrocardiograms (table III) . More of the controls had symptoms of angina or possible myocardial infarction and were receiving long term treatment. Electrocardiograms were analysed blind using the Minnesota code. Five electrocardiographic abnormalities suggestive of ischaemia developed in the control group compared with one in the group taught to relax. There was also one fatal myocardial infarction in the control group proved at necropsy. Fisher's exact test for these objective data showed the difference between the groups to be significant (p < 0 05). Three deaths from cancer occurred, two in the treated and one in the control group. One of these deaths was in a subject in the treated group who was known to have had pneumonectomy for carcinoma of the bronchus before the study began.
Discussion
In our previous report we discussed the possibilities of bias and concluded that the changes in blood pressure were was a 22%, 15%, and 120% reduction in risk of coronary heart disease at eight weeks, eight months, and four years, respectively, using a multiple logistic function from the London Whitehall study. The reduction in the incidence of new electrocardiographic abnormalities at four years was greater than predicted. This may have been the result of chance variation, but it may suggest that relaxation affects pathways other than the established cardiac risk factors.
Introduction
A survey of notifications of tuberculosis in England and Wales in 1978 showed that disease of the lymph nodes was the commonest form of non-respiratory tuberculosis.' The British Thoracic Association's first controlled trial of chemotherapy for tuberculosis of lymph nodes compared two 18 month regimens in 90 patients.2 3 The regimens comprised either rifampicin plus isoniazid or ethambutol plus isoniazid, both supplemented with streptomycin for the first two months. A satisfactory response to chemotherapy was seen, and microbiological relapse did not occur when treatment was stopped. In a retrospective study of lymph node tuberculosis Summers and McNicol reported no relapse in 239 patients, some of whom were treated with nine month regimens incorporating rifampicin and isoniazid. 4 Our study compares treatment with rifampicin and isoniazid given for either nine or 18 months, supplemented initially by eight weeks' treatment with ethambutol. We describe the state of patients 36 months after entry to the study.
